BrainTumorCharity

Mashup Score: 7

MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas - 2 year(s) ago

Nature Communications – The MAPK pathway is a key driver of pediatric low-grade gliomas (pLGG); however, response to MAPK inhibitors (MAPKi) in pLGG patients is not consistent. Here, the authors…

Source: www.nature.com

Categories: General Medicine News, Latest Headlines

Tweet Tweets with this article
- NatureComms
  
  Researchers @KiTZ_HD @BrainTumorOrg develop MAPK inhibitor sensitivity scores to predict response in paediatric low-grade #glioma #ChildhoodCancer #BrainTumorCharity #CancerResearch @NatResCancer https://t.co/qP1djxyObL